Qube Research & Technologies (QRT)
CRBP icon

Qube Research & Technologies (QRT)’s Corbus Pharmaceuticals CRBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,476
Closed -$173K – 3553
2026
Q1 		$173K Buy
18,476
+2,562
+16% +$21.6K ﹤0.01% 2987
2025
Q4 		$130K Buy
+15,914
New +$196K ﹤0.01% 3141
2024
Q4 		– Sell
-15,321
Closed -$316K – 3504
2024
Q3 		$316K Buy
15,321
+14,575
+1,954% +$746K ﹤0.01% 2409
2024
Q2 		$33.8K Sell
746
-8,906
-92% -$375K ﹤0.01% 2806
2024
Q1 		$379K Buy
+9,652
New +$238K ﹤0.01% 2688
2021
Q4 		– Sell
-415
Closed -$13K – 2587
2021
Q3 		$13K Buy
+415
New +$16.4K ﹤0.01% 2015

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRBP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Corbus Pharmaceuticals (CRBP) in Q2 2026, closing a stake of 18,476 shares — an estimated $173K sold.

Qube Research & Technologies (QRT) first reported a position in CRBP in Q3 2021 and held it in 6 quarters. The position peaked at $379K in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Corbus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 18,476 Corbus Pharmaceuticals shares in Q2 2026, an estimated $173K.
  • Qube Research & Technologies (QRT) first reported a position in Corbus Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Corbus Pharmaceuticals position peaked at $379K in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.